Translational Research in Maternal and Pediatric Pharmacology and Therapeutics (R21 Clinical Trial Optional)
Translational Research in Maternal and Pediatric Pharmacology and Therapeutics (R21 Clinical Trial Optional) is a published development and funding opportunity on Contexium. The donor or funder is National Institutes of Health. Project location(s): United States. Applications close on 06 Jul 2026. The purpose of this notice of funding opportunity (NOFO) is to support translational and clinical research to (1) advance precision medicine in pregnant women, lactating women, and children through the development of novel tools, models, and other technologies that could have a direct clinical or he…
Opportunity overview
- Project name
- Translational Research in Maternal and Pediatric Pharmacology and Therapeutics (R21 Clinical Trial Optional)
- Donor
- National Institutes of Health
Key details
- Opportunity start date
- Opportunity end date
- Project location(s)
- United States
Summary
Frequently asked questions
What is Translational Research in Maternal and Pediatric Pharmacology and Therapeutics (R21 Clinical Trial Optional)?
Translational Research in Maternal and Pediatric Pharmacology and Therapeutics (R21 Clinical Trial Optional) is a published development and funding opportunity on Contexium. The donor or funder is National Institutes of Health. Project location(s): United States. Applications close on 06 Jul 2026. The purpose of this notice of funding opportunity (NOFO) is to support translational and clinical research to (1) advance precision medicine in pregnant women, lactating women, and children through the development of novel tools, models, and other technologies that could have a direct clinical or he…
Who is funding Translational Research in Maternal and Pediatric Pharmacology and Therapeutics (R21 Clinical Trial Optional)?
Translational Research in Maternal and Pediatric Pharmacology and Therapeutics (R21 Clinical Trial Optional) is funded by National Institutes of Health.
When is the deadline to apply for Translational Research in Maternal and Pediatric Pharmacology and Therapeutics (R21 Clinical Trial Optional)?
The application deadline is 06 Jul 2026 00:00 (UTC).
Where will the Translational Research in Maternal and Pediatric Pharmacology and Therapeutics (R21 Clinical Trial Optional) project take place?
The project location(s) are: United States.
How can I apply for Translational Research in Maternal and Pediatric Pharmacology and Therapeutics (R21 Clinical Trial Optional)?
Create a free Contexium account to view the full opportunity details and submit an application via the marketplace.